Qube Research & Technologies LTD Centessa Pharmaceuticals PLC Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 29,434 shares of CNTA stock, worth $487,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,434
Previous 107,058
72.51%
Holding current value
$487,427
Previous $1.79 Million
76.41%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CNTA
# of Institutions
135Shares Held
123MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$331 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$165 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$160 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$115 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$98.1 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.56B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...